// App-Quantinova.ai

e21076 : Predictive biomarkers of response to anti-PD-1 treatment in non-small cell lung cancer patients.

Researchers

Presenter

  • Xuan Zheng

Principal Investigators

  • Yi Hu

Medical Centers

  • Chinese PLA General Hospital, Bei Jing, China

  • PLA GENERAL HOSPITAL, Bei Jing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved